BrightEdge Fund

BrightEdge Fund is the American Cancer Society’s donor-funded, philanthropic impact fund in Atlanta that invests in companies developing novel cancer-focused therapies and technologies. Founded 2018 in Atlanta, Georgia, United States, this corporate venture capital firm invests in early stage ventures. Its portfolio companies include Tmunity Therapeutics, Navigating Cancer, Freenome, and Castle Biosciences. As of February 2020, BrightEdge Fund has made 4 investments. Their most recent investment was on Oct 31, 2019, when Tmunity Therapeutics raised $75M. BrightEdge Fund has had 1 exit, which was Castle Biosciences.